Evidence map›Paper›PMID 34804163›Full record

ReviewAdvances in virology2021

A Narrative Review of Existing Options for COVID-19-Specific Treatments.

Wasey Ali Yadullahi Mir, Abdul Hasan Siddiqui, Gautam Valecha, Shawn Patel, Fatima Ayub, Riddhi Upadhyay, Sana Ahmed Alhajri, Suman Gaire, Dhan Bahadur Shrestha

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Advances in virology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Wasey Ali Yadullahi MirDepartment of Internal Medicine, Mount Sinai Hospital, Chicago, IL, USA.ORCID https://orcid.org/0000-0003-1450-3701
Abdul Hasan SiddiquiDepartment of Oncology, Presbyterian Healthcare Services, Albuquerque, NM, USA.
Gautam ValechaDepartment of Oncology, Presbyterian Healthcare Services, Albuquerque, NM, USA.
Shawn PatelDepartment of Internal Medicine, The Carle Illinois College of Medicine, Champaign, IL, USA.
Fatima AyubDepartment of Internal Medicine, The Carle Illinois College of Medicine, Champaign, IL, USA.
Riddhi UpadhyayDepartment of Internal Medicine, The Carle Illinois College of Medicine, Champaign, IL, USA.
Sana Ahmed AlhajriDepartment of Pediatrics, University of Illinois Chicago, Chicago, IL, USA.
Suman GaireDepartment of Emergency Medicine, Palpa Hospital, Palpa, Nepal.ORCID https://orcid.org/0000-0002-1323-7918
Dhan Bahadur ShresthaDepartment of Internal Medicine, Mount Sinai Hospital, Chicago, IL, USA.ORCID https://orcid.org/0000-0002-8121-083X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The new coronavirus disease 2019 (COVID-19) was declared a global pandemic in early 2020. The ongoing COVID-19 pandemic has affected morbidity and mortality tremendously. Even though multiple drugs are being used throughout the world since the advent of COVID-19, only limited treatment options are available for COVID-19. Therefore, drugs targeting various pathologic aspects of the disease are being explored. Multiple studies have been published to demonstrate their clinical efficacy until now. Based on the current evidence to date, we summarized the mechanism, roles, and side effects of all existing treatment options to target this potentially fatal virus.

Identifiers

PMID34804163
PMCPMC8604608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.